Loss of S1P Lyase Expression in Human Podocytes Causes a Reduction in Nephrin Expression That Involves PKCδ...

Area of Science:

• Nephrology
• Molecular Biology
• Lipid Metabolism

Background:

• Sphingosine 1-phosphate (S1P) lyase (SPL) degrades S1P, regulating cellular functions.
• Mutations in the SPL gene cause severe nephrotic syndrome, highlighting its role in kidney filtration.
• Podocytes are crucial for the glomerular ultrafiltration barrier.

Purpose of the Study:

• Investigate the molecular mechanisms of SPL loss in human podocytes.
• Understand the pathogenesis of nephrotic syndrome linked to SPL mutations.

Main Methods:

• Generated a stable SPL-knockdown (kd) human podocyte cell line using lentiviral shRNA.
• Analyzed SPL mRNA and protein levels, S1P levels, and expression of podocyte-specific proteins.
• Assessed the role of protein kinase C (PKC) and interleukin-6 (IL-6) in regulating nephrin and WT1 expression.

Main Results:

• SPL knockdown reduced nephrin and WT1 mRNA and protein expression.
• Increased PKC activity was observed in SPL-kd podocytes; inhibiting PKCδ restored nephrin expression.
• Interleukin-6 reduced WT1 and nephrin expression and activated PKCδ.

Conclusions:

• Loss of SPL leads to nephrin downregulation, potentially causing podocyte foot process effacement and albuminuria in nephrotic syndrome.
• PKCδ is identified as a potential therapeutic target for SPL mutation-induced nephrotic syndrome.